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Educational Needs Assessment and the Management of 
Chronic Kidney Disease in a Malaysian Setting: A Review 
dialysis was predicted to increase to more than 
30,000 by the end of 2015 (2). This statistic high-
lights the need to prevent the deterioration of 
CKD to end stage renal failure (ESRF), and this 
requires collaborative preventive measures from 
multidisciplinary healthcare professionals. Thus, 
further research should be carried out to assess 
the educational needs of CKD patients at risk of 
ESRF, in line with the Ministry of Health’s (MOH) 
requirement that each healthcare professional 
(HCP) must play a role in advising, educating, and 
empowering self-care management tailored to the 
needs of patients (3, 4).  
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ABSTRACT 
 
Chronic kidney disease is among the top ten causes of mortality in Malaysia. An increase in the pattern of 
dialysis recipients has been observed, rising from 325 per million population in 2001 to 762 per million 
population in 2010. Chronic kidney disease is characterised by irreversible loss of renal function for at 
least three months, and the risk factors for chronic kidney disease include diabetes mellitus, hyperten-
sion, cardiovascular disease, dyslipidaemia, and lifestyle risk factors such as poor dietary patterns, lack 
of exercise or physical activity, smoking, and increased alcohol intake. Thus, appropriate educational 
needs assessment is required to begin modifying these risk factors via educational intervention to delay 
disease progress and to prevent patients reaching end stage renal failure. The aim of this article is to 
provide a review of the existing literature on the chronic kidney disease process, based on recommended 
primary and secondary management from both medical aspects and lifestyle modification requirements, 
highlighting the importance of patient education. 
 
KEYWORDS: Chronic kidney disease, Education needs, Risk factors, Lifestyle modification, Management 
 
INTRODUCTION 
 
Kidney dysfunction is classified into several catego-
ries including acute renal failure (ARF), chronic 
kidney disease (CKD), and end stage renal failure 
(ESRF). Its causes include glomerulonephritis, poly-
cystic kidney disease (PKD), Immunoglobulin A (IgA) 
nephropathy, lupus nephritis, nephrotic syndrome, 
and kidney cancer. Of these, CKD is most common-
ly recognized as a public health problem world-
wide, and it has become a major issue in both de-
veloped and developing countries, including Malay-
sia.  
 
Table I illustrates the staging of CKD according to 
Malaysian standard guidelines. CKD is defined as 
kidney damage with a glomerular filtration rate 
(GFR) of less than 60 ml/min/1.73 2 for at least 
three months. Lee, Wu, and Hsieh (2016) mention 
that CKD is associated with an increased risk of 
death by cardiovascular disease, as well as influ-
encing individual’s psychological and physical well-
being, affecting their quality of life, and posing a 
heavy burden on the nation’s health care system 
(1).  
 
Stages of CKD 
 
Stage 
 
GFR 
(ml/min/1.73m2) 
 
Description 
 
1 
 
≥90 
 
Normal or increased GFR, 
with other evidence of 
kidney damage 
 
2 
 
60 - 89 
 
Slight decrease in GFR, 
with other evidence of 
kidney damage 
 
3A 
 
45 - 59 
 
Moderate decrease in GFR, 
with or without other evi-
dence of kidney damage 
 
3B 
 
30 - 44 
 
4 
 
15 - 29 
 
Severe decrease in GFR, 
with or without other evi-
dence of kidney  
damage 
 
5 
 
<15 
 
Established renal failure 
Table I:  Staging of chronic kidney disease 
(Source: Malaysia Ministry of Health, Clinical Practice 
Guideline, 2012) 
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In Malaysia, the Ministry of Health Malaysia (2011) 
noted that the ratio of patients with CKD is trend-
ing upwards, and this is predicted to continue. 
There are likely to be more than 5,000 new pa-
tients diagnosed with kidney failure every year, 
and thus the number of Malaysians dependent on  
                                                                                                                                                                                                                      35 
International Journal of Care Scholars 2018;1(1) 
A. Diabetes mellitus 
 
Diabetes mellitus is the most prominent risk factor 
for CKD in Malaysia (6, 7). According to the co-
Chair of International Congress of the International 
Society for Haemodialysis (2015), 58 percent of 
diabetic patients could eventually develop kidney 
failure (2). Diabetes mellitus contributes to the 
development of CKD by affecting the glucose levels 
in the vascular system after insulin regulatory 
mechanism failure, contributing to insulin re-
sistance and hyperglycaemia (8). 
 
Tight glycaemic control (Hb A1c < 6%) should be 
maintained to reduce micro vascular, and possibly 
macrovascular, complications (9, 10). Optimal 
blood glucose control would also have the added 
effect of further improving the symptoms of polyu-
ria and polydipsia among CKD patients (8). Thus, 
all CKD patients with DM should be encouraged to 
adopt therapeutic lifestyle changes such as in-
creasing physical activity and practicing healthy 
dietary patterns. 
 
B. Hypertension  
 
In the Malaysian setting, HTN is the second lead 
cause of kidney disease, with up to 95% of the 
165,000-people affected having been reported as 
having CKD (11). It is thus highly recommended 
that CKD patients aim to achieve optimum blood 
pressure control of less than 140/90 mmHg, with 
potassium levels ranging between 5.5 to 6.0 mmol/
L to minimise cardiovascular and other diabetic 
complications (8). Two or more drugs may be nec-
essary for the retardation of renal disease progres-
sion, especially among those with diabetes (4), to 
reduce the onset of diabetic nephropathy which is 
often associated with metabolic syndrome, obesi-
ty, insulin resistance, and hyperlipidaemia. 
 
C. Cardiovascular disease  
 
Cardiovascular disease is one of the complications 
associated with increased mortality among pa-
tients with CKD (11). The NKF (2016) supports the 
findings of Hill et al. (2016), who stated that kid-
ney disease is the 9th leading cause of death in the 
United States of America (USA), with associated 
higher risks of morbidity and mortality. It is also 
well known that CKD causes anaemia that may lead 
to worsening ischaemia, and eventually heart fail-
ure, in patients with concomitant CVD (5). CKD 
patients with severe atherosclerotic diseases may 
also develop cerebrovascular accidents (CVA) or 
have strokes due to higher levels of tumour necrot-
ic factor-a (TNF-a), interleukin 1 (IL 1), and inter-
leukin 6 (IL 6) in their blood. Cytokines are also 
prominent factors in the development of malnutri-
tion-inflammatory-atherosclerosis (MIA) syndrome 
in ESRF patients (12). 
 
D. Smoking 
 
There is a clear epidemiological evidence that links 
smoking with increased risk of cardiovascular 
events (13). Furthermore, smoking has been associ-
ated with accelerated progression of diabetic and 
non-diabetic renal disease, thereby necessitating 
early cessation of smoking, which can ameliorate 
the decline of renal function. To date, there have 
been no randomized clinical trials (RCTs) to show 
the impact of smoking cessation on the progression 
of CKD; nevertheless, smoking cessation is neces-
sary to retard the progression of renal disease, es-
pecially among those with diabetic nephropathy 
(8). 
 
E. Dyslipidaemia 
 
CKD is associated with dyslipidaemia, a known risk 
factor for CVD. It is also common for diabetic pa-
tients to have abnormal lipid profiles with raised 
serum triglycerides and cholesterol and decreased 
high-density lipoprotein (HDL) cholesterol levels. 
Thus, full lipid profile should be performed at least 
annually in adult diabetics, regardless of their pre-
morbid lipid profiles (4). 
 
F. Other risk factors 
 
There is lack of evidence on the effectiveness of 
lifestyle modification in terms of preventing renal 
or cardiovascular end-points (4, 8). Studies on the 
effects of alcohol consumption on CKD have also 
been inconclusive. Nevertheless, it is prudent to 
adopt lifestyle changes such as reducing central 
obesity and cigarette smoking. Certain risk factors 
are also linked with CKD development, such as hav-
ing an autoimmune disease, nephrolithiasis, anae-
mia, hyperuricaemia, and nocturia. In terms of so-
cial factors, those with low socio-economic status, 
low birth weights of < 2,500g, and users of herbal 
products containing aristolochic acid as a routine 
regimen may be at greater risk of developing CKD. 
 
Medical management of kidney disease 
 
There are several important steps in the medical 
management of CKD, which include fluid restriction 
and close monitoring of glucose and blood pressure 
levels. Renal replacement therapy (RRT) may be 
prescribed by physicians if the patient’s condition 
deteriorates further and they fulfil the strict crite-
ria for RRT. 
 
A. Fluid restriction 
Fluid restriction, especially in advanced and end-
stage CKD, is not limited to liquids drunk directly 
by CKD patients but also includes the fluid content 
of foods such as soup and the juice content in fruits 
and vegetables. A cohort study conducted among 
188 respondents from 14 dialysis centres in Malay-
sia found that most respondents were non-
compliant with dietary (63.8%) and fluid (51.6%) 
restrictions, being only slightly more compliant 
with medications (49.5%), but rigorous in dialysis 
attendance (8.5%). The barriers causing non-
compliance include lack of knowledge or infor-
mation, unfavourable food preferences, lifestyle 
alteration resistance, and treatment complexity 
(14).  
Risk factors for developing chronic kidney  
disease 
 
There are two major types of risk factors for CKD, 
non-modifiable and modifiable. Non-modifiable 
risk factors as a term refers to genetically inherit-
ed diseases such as hypertension (HTN), diabetes 
mellitus (DM), cardiovascular disease (CVD), and 
hyperlipidaemia (HPL), while modifiable risk fac-
tors include lifestyle related factors such as smok-
ing, alcohol intake, central obesity, physical inac-
tivity, low socio-economic status, and consuming 
herbal medicine containing aristolochic acid, 
which is commonly used in Chinese herbal medi-
cine. There are also several other conditions 
linked to CKD such as autoimmune disease, neph-
rolithiasis, anaemia, hyperuricaemia, and nocturia 
(5); however, this review paper only has space to 
discuss certain prominent conditions based on well
-established literature. 
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B. Glucose and blood pressure control 
Patients with CKD are required to control their 
blood pressure and glucose levels within tight pa-
rameters in order to effectively retard CKD pro-
gression (8). Patients are recommended to limit 
their protein intakes to reduce albuminuria and to 
lower their HbA1c levels to approximately 6.5% to 
7% to prevent diabetic nephropathy. However, a 
recent study by Seok HK et al (2015) highlighted 
that monitoring HbA1c only is inadequate. An in-
verse relationship using a regression model was 
observed between the estimated glomerular fil-
tration rate (eGFR) and HbA1c, wherein a de-
crease of eGFR was associated with an increase in 
HbA1c levels (15). Thus, HbA1c may be underesti-
mated in patients with advanced CKD. Regular 
capillary glucose measurements are thus required 
for accurate assessment of glycaemic control (4), 
and hence it is advisable for each CKD patient 
with diabetes to keep a record of their capillary 
glucose readings throughout the day. 
 
C. Renal Replacement Therapy  
Renal replacement therapy (RRT) includes perito-
neal dialysis, haemodialysis, and renal transplant, 
and it is highly recommended that continuous RRT 
is adopted in the medical and nursing manage-
ment of patients with ESRF (16). 
 
i) Peritoneal dialysis 
In 2014, staggering 7,980 patients in Malaysia un-
derwent peritoneal dialysis treatment, with a rec-
orded incidence of CKD of almost 1,182 per mil-
lion population in that year (2, 17). Although this 
spike in incidence may yet prove to be an aberra-
tion, as its causes are still largely unknown, it 
does fit into the general trend of increasing CKD 
in the population (18). 
 
ii) Haemodialysis 
Haemodialysis is a treatment that uses a dialyzer 
as an artificial kidney to remove fluid and waste 
products from the blood. Haemodialysis is still the 
predominant mode of treatment for ESRF patients 
in most countries, including Malaysia (19). This is 
supported by statistical findings that highlight the 
fact that almost 27,600 patients received haemo-
dialysis in Malaysia throughout 2014 (2). 
 
iii) Renal transplant 
A transplanted kidney may come from either a 
living or cadaveric donor. Increased precautions 
are needed when performing renal transplants in 
diabetic patients due to their risk of mortality 
being two to four times higher compared to non-
diabetic patients (including patients with cardio-
vascular disease) (4). Although having a trans-
planted kidney will remove the need for dialysis in 
patients with ESRF, they will still need to control 
their other diseases and risk factors causing ESRF, 
Lifestyle modification among CKD patients 
 
To date, no major study has been conducted to 
determine whether lifestyle modification is rele-
vant for primary or secondary prevention in CKD 
patients (4). Nevertheless, patients with CKD 
should be encouraged to exercise or become more 
physically active, practise healthy dietary intake 
patterns, reduce excess weight, and avoid smok-
ing to reduce their risk of developing ESRF. 
 
A. Physical activity 
Research has highlighted that exercise improves 
physical activity levels and sleep quality among 
CKD patients receiving long-term haemodialysis, 
thus indirectly enhancing quality of life. Further-
more, regular exercise has the added benefit of 
reducing obesity rates (13). Several studies have 
also highlighted the prevalence of poor physical 
activity levels amongst dialysis patients in Malay-
sia, especially among less literate patients (20). 
This may be due to the side effects of dialysis, 
which include fatigue that can lead to low physi-
cal activity levels, as highlighted by Maniam et al 
(21).  
 
B. Dietary modification 
In a study conducted by Nor Baizura et al (2013), 
it was found that haemodialysis was highly associ-
ated with malnutrition (19). Thus, CKD patients 
need to follow dietary guidelines provided by phy-
sicians and dieticians to prevent complications 
such as anaemia, bone disease, metabolic acido-
sis, hyperkalaemia, and hyperparathyroidism dis-
ease (5). A dietician is best placed to decide on 
the prescription for macronutrient and micronu-
trient intakes after a complete assessment has 
been performed by a physician. 
Information needs of CKD patients 
 
Most CKD patients have many concerns regarding 
their disease process, risk factor management, 
complication management, self-care manage-
ment, treatment options, and logistical matters, 
which include financial assistance, transportation, 
and waiting lists for renal transplants (17, 22).  
 
A. General information on CKD 
The type of information needed by CKD patients 
varies according to the severity of kidney damage. 
According to Rose, Groenhoff, and Zin (2004), as 
cited in Lewis, Stabler, and Welch (2010), in the 
earlier stages of being diagnosed with CKD, pa-
tients will focus their informational needs on the 
disease process (23). At this stage, CKD patients 
require an understanding of the definition, classi-
fication, causes, and symptoms of CKD; generally, 
patients at this stage are asymptomatic, as found 
in studies by Kumaradivel et al (2016) and Siti 
Noorkhairina et al (2014) among patients in Malay-
sia (24, 10), and it is important that CKD patients 
follow the prescriptions given by healthcare pro-
fessionals (HCP). 
  
B. Risk factor management 
 
DM and HTN are the common causes of CKD. How-
ever, a recent study by Ng, Lee, and Goh (2016) 
indicated that the Malaysian population is inade-
quately informed about CKD, even among those 
who are at risk of encountering CKD complica-
tions. It is also important to monitor patients with 
systemic lupus erythematosus (SLE), glomerulone-
phritis, obstructive nephropathy, and polycystic 
kidney who are at risk of developing CKD (25). 
 
C. Complication management  
CVD is a known complication of kidney disease, 
and the number one killer of patients with CKD 
(11). CKD patients need to be educated to recog-
nise the tell-tale signs of CVD such as oedema. 
They should also be on the lookout for signs of 
other common complications such as anaemia, 
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hyperparathyroidism, and bone disease (Malaysia 
Ministry of Health, Clinical Practice Guideline, 
2011). Highlighting this issue during patient edu-
cation will enhance patients' knowledge and com-
pel them to take preventive measure. 
 
D. Self-care management 
Pre-dialysis and self-care education is important 
for improving patient outcomes, especially for 
patients with stage four CKD. Lewis, Stabler, and 
Welch (2010) stated that the top four educational 
needs amongst patients prior to starting dialysis 
were knowledge of kidney disease (96%); graft, 
fistula, and catheter insertion and care (83%); 
treatment options (83%); and taking medications 
correctly (80%) (23). Thus, each HCP should shoul-
der the responsibility of delivering all the neces-
sary information prior to patients’ discharge. 
 
E. Treatment options 
Pre-dialysis education is important for improving 
patient outcomes, especially for patients with 
stage four CKD. Harwood et al (2005), as cited by 
Lewis and Stabler (2010) (25), mentioned that 
patients with CKD have specific stressors prior to 
the initiation of dialysis such as physical symp-
toms, psychosocial issues, logistical problems re-
garding the clinic itself (e.g. scheduling, multiple 
appointments, and waiting lists), and lack of in-
formation on the dialysis procedure. Lederer et al 
(2016) reported that patients most desired infor-
mation about treatment options for kidney failure 
(including dialysis and kidney transplants) and the 
relationship between CKD and other chronic med-
ical conditions (26). Thus, dissemination of infor-
mation by multidisciplinary HCPs may increase 
the level of patients’ knowledge and awareness of 
preventative care; increase compliance with med-
ication, especially in terms of the prescription of 
aspirin and lipid lowering agents for secondary 
prevention of CVD; decrease hospitalization; lead 
to improvement in disease-specific outcomes; 
and, eventually, contribute to greater patient 
Role of nurses as educator 
 
Patient education has long been considered a 
major component of the standard care given by 
nurses. Nursing is usually the health care profes-
sion in closest proximity with patients, and stud-
ies have highlighted that patients receive addi-
tional information about healthcare from nurses 
(25). According to Bastable (2008), the purpose 
of patient education is to increase the compe-
tence and confidence of patients in terms of self-
management, and to prepare patients for self-
care (27). Furthermore, effective teaching by 
HCPs, including physicians and nurses, has the 
potential to increase satisfaction, improve quali-
ty of life, ensure continuity of care, decrease 
patient anxiety, effectively reduce the complica-
tions of illnesses, and energize and empower pa-
tients to become actively involved in planning of 
their own care (28,29). Carpenter and Bell (2002) 
proposed that the education process should be 
enacted within a framework that facilitated a 
participatory, shared approach to teaching and 
learning (27). 
 
The importance of educational needs assess-
ment 
 
Educational need is the gap between what a per-
son knows and what they need or want to know. 
CONCLUSION 
 
The increasing rate of CKD occurrence in Malaysia 
highlights a gap in care which allows a majority of 
patients to remain non-compliant towards dietary 
practice changes, fluid restriction, medication 
usage, dialysis attendance, and maintaining an 
overall healthy lifestyle, all of which if adhered to 
could delay the disease reaching ESRF. More effec-
tive strategies of patient education intervention 
thus need to be adopted as routine to improve 
compliance behaviours and quality of life among 
patients and their family members. Detailed edu-
cational needs assessments must be conducted to 
ensure effective patient education, which should 
then further increase satisfaction among patients 
in terms of their treatment and lead to better self
-care and disease management. 
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There are several important steps in the assess-
ment of educational needs:  
1) identifying the learner; 2) choosing the right set-
ting; 3) collecting data about the learner; 4) col-
lecting data from the learner; 5) involving a multi-
disciplinary healthcare team; 6) prioritising patient 
needs; 7) determining the availability of education-
al resources; and 8) assessing the demands on the 
organisation (13, 27, 30, 31). These information 
needs may be obtained via informal conversations, 
structured interviews, focus groups, self-
administered questionnaires, specific tests, obser-
vations, and patient charts (31). As HCPs, the en-
tire HCP team is responsible for empowering pa-
tients and their family members to achieve self-
management prior to hospital discharge and before 
being referred for further follow up, thus, increas-
ing their involvement in the caring process associ-
ated with better health outcomes, as well as im-
proving the healthcare service as highlighted in the 
KPI set by MOH Malaysia. 
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